SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 18.18
+0.18 (1.00%)
Jan 22, 2026, 2:58 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 47.25 million as of January 22, 2026. Its market cap has increased by 29.28% in one year.
Market Cap
47.25M
Enterprise Value
43.46M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.18
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 47.25M, an increase of 200.41%. That is a compound annual growth rate of 13.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 47.25M | 15.93% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 134.91M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| Hemogenyx Pharmaceuticals | 41.56M |
| hVIVO | 37.76M |
| Ondine Biomedical | 35.54M |
| ImmuPharma | 34.69M |
| Poolbeg Pharma | 34.16M |